Literature DB >> 20932170

Poor clinical outcome for meningitis caused by Haemophilus influenzae serotype A strains containing the IS1016-bexA deletion.

Josilene B T Lima1, Guilherme S Ribeiro, Soraia M Cordeiro, Edilane L Gouveia, Kátia Salgado, Brian G Spratt, Daniel Godoy, Mitermayer G Reis, Albert I Ko, Joice N Reis.   

Abstract

Since the introduction of Haemophilus influenzae type b (Hib) conjugate vaccines, meningitis caused by serotypes other than Hib has gained in importance. We conducted active hospital-based surveillance for meningitis over an 11-year period in Salvador, Brazil. H. influenzae isolates were serotyped and analyzed by polymerase chain reaction, pulsed-field gel electrophoresis, and DNA sequencing to identify strains with a specific deletion (IS1016) in the bexA gene (IS1016-bexA). We identified 43 meningitis cases caused by non-type b H. influenzae: 28 (65%) were caused by type a (Hia), 9 (21%) were caused by noncapsulated strains, and 3 (7%) each were caused by types e and f. Hia isolates clustered in 2 clonal groups; clonal group A strains (n = 9) had the IS1016-bexA deletion. Among children <5 years of age, meningitis caused by Hia from clonal group A had higher case-fatality than meningitis caused by clonal group B. Despite small numbers, these results indicate that the presence of the IS1016-bexA deletion is associated with enhanced virulence in non-type b H. influenzae.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932170      PMCID: PMC2957550          DOI: 10.1086/656778

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia.

Authors:  H Peltola; P Aavitsland; K G Hansen; K E Jónsdóttir; H Nøkleby; V Romanus
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

2.  Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.

Authors:  Richard A Adegbola; Ousman Secka; George Lahai; Nellie Lloyd-Evans; Alpha Njie; Stanley Usen; Claire Oluwalana; Stephen Obaro; Martin Weber; Tumani Corrah; Kim Mulholland; Keith McAdam; Brian Greenwood; Paul J M Milligan
Journal:  Lancet       Date:  2005 Jul 9-15       Impact factor: 79.321

3.  Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003.

Authors:  Eugene V Millar; Katherine L O'Brien; James P Watt; Jairam Lingappa; Ravi Pallipamu; Nancy Rosenstein; Diana Hu; Raymond Reid; Mathuram Santosham
Journal:  Clin Infect Dis       Date:  2005-02-18       Impact factor: 9.079

4.  Invasive Haemophilus influenzae type b disease in Sweden 1997-2003: epidemiological trends and patterns in the post-vaccine era.

Authors:  Daniel Farhoudi; Margareta Löfdahl; Johan Giesecke
Journal:  Scand J Infect Dis       Date:  2005

5.  Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era.

Authors:  Raymond S W Tsang; Samira Mubareka; Michelle L Sill; John Wylie; Stuart Skinner; Dennis K S Law
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with hib polyribosylribitol phosphate polysaccharide-tetanus toxoid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine.

Authors:  E Forleo-Neto; C F de Oliveira; E M Maluf; C Bataglin; J M Araujo; L F Kunz; A K Pustai; V S Vieira; R C Zanella; M C Brandileone; L M Mimica; I M Mimica
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

7.  Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.

Authors:  Bill G Kapogiannis; Sarah Satola; Harry L Keyserling; Monica M Farley
Journal:  Clin Infect Dis       Date:  2005-10-25       Impact factor: 9.079

8.  Outbreak of invasive Haemophilus influenzae serotype a disease.

Authors:  Laura L Hammitt; Susanna Block; Thomas W Hennessy; Carolyn Debyle; Helen Peters; Alan Parkinson; Rosalyn Singleton; Jay C Butler
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

9.  Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group.

Authors:  R Dagan; D Fraser; M Roitman; P Slater; E Anis; S Ashkenazi; I Kassis; D Miron; A Leventhal
Journal:  Vaccine       Date:  1999-01       Impact factor: 3.641

10.  Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.

Authors:  Guilherme S Ribeiro; Josilene B T Lima; Joice N Reis; Edilane L Gouveia; Soraia M Cordeiro; Tatiana S Lobo; Ricardo M Pinheiro; Cássio T Ribeiro; Alan B Neves; Kátia Salgado; Hagamenon R Silva; Mitermayer G Reis; Albert I Ko
Journal:  Vaccine       Date:  2007-03-30       Impact factor: 3.641

View more
  12 in total

1.  Emergence of non-serotype b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in northwestern Ontario.

Authors:  Pouya Sadeghi-Aval; Raymond Sw Tsang; Frances B Jamieson; Marina Ulanova
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

2.  Blood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A2A and A2B.

Authors:  N Caporarello; M Olivieri; M Cristaldi; M Scalia; M A Toscano; C Genovese; A Addamo; M Salmeri; G Lupo; C D Anfuso
Journal:  Mol Neurobiol       Date:  2017-09-18       Impact factor: 5.590

3.  Distribution of strain type and antimicrobial susceptibility of Escherichia coli isolates causing meningitis in a large urban setting in Brazil.

Authors:  Hillary Berman; Maria Goreth Barberino; Edson Duarte Moreira; Lee Riley; Joice N Reis
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

4.  Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil.

Authors:  T Coelho-Souza; J N Reis; N Martins; I S Martins; A O Menezes; M G Reis; N O Silva; R C S Dias; L W Riley; B M Moreira
Journal:  Clin Microbiol Infect       Date:  2013-02-11       Impact factor: 8.067

Review 5.  Long Term Impact of Conjugate Vaccines on Haemophilus influenzae Meningitis: Narrative Review.

Authors:  Mary Paulina Elizabeth Slack
Journal:  Microorganisms       Date:  2021-04-21

6.  Nontypable Haemophilus influenzae displays a prevalent surface structure molecular pattern in clinical isolates.

Authors:  Pau Martí-Lliteras; Antonio López-Gómez; Silvia Mauro; Derek W Hood; Cristina Viadas; Laura Calatayud; Pau Morey; Alain Servin; Josefina Liñares; Antonio Oliver; José Antonio Bengoechea; Junkal Garmendia
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

7.  The epidemiology of invasive disease due to Haemophilus influenzae serotype a in the Canadian North from 2000 to 2010.

Authors:  Jenny L Rotondo; Lindsey Sherrard; Melissa Helferty; Raymond Tsang; Shalini Desai
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

8.  Haemophilus influenzae Type a Meningitis in Immunocompetent Child, Oman, 2015.

Authors:  Kiran P Sawardekar
Journal:  Emerg Infect Dis       Date:  2017-07       Impact factor: 6.883

9.  Invasive Haemophilus influenzae disease in the vaccine era in Rio de Janeiro, Brazil.

Authors:  Mari Tuyama; Jessica Corrêa-Antônio; Jessica Schlackman; Jane W Marsh; Maria C Rebelo; Elaine O Cerqueira; Márcio Nehab; Fabíola Kegele; Getúlio F Carmo; Dominique Ca Thielmann; Paulo F Barroso; Lee H Harrison; David E Barroso
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02-16       Impact factor: 2.743

10.  Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011.

Authors:  Michael G Bruce; Tammy Zulz; Carolynn DeByle; Ros Singleton; Debby Hurlburt; Dana Bruden; Karen Rudolph; Thomas Hennessy; Joseph Klejka; Jay D Wenger
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.